CSBR Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 10:30):

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States...

Stats
Today's Volume	138.00
Average Volume	4 114.00
Market Cap	69.85M
EPS	$-0.160 ( 2024-03-20 )
Next earnings date	( $-0.160 ) 2024-07-22
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-7.14
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2023-10-09	Davis Brady	Buy	68 000	Option to purchase Common Stock
2023-10-09	Davis Brady	Buy	7 500	Option to purchase Common Stock
2023-10-09	Davis Brady	Buy	135 000	Option to purchase Common Stock
2024-01-12	Mendelson Daniel Newman	Buy	1 000	Common Stock
2024-01-11	Mendelson Daniel Newman	Buy	2 000	Common Stock

INSIDER POWER
88.84
Last 100 transactions
Buy: 1 237 465 \| Sell: 480 213

Champions Oncology Inc Correlation

10 Most Positive Correlations
VCSA	0.965
OPTN	0.965
AGZD	0.957
STSA	0.955
TOI	0.945
IMRX	0.94
ONCS	0.94
ADSE	0.933
TCDA	0.931
VSTA	0.93

10 Most Negative Correlations
ARNA	-0.953
CCRC	-0.938
PBFS	-0.922
MACK	-0.917
APEN	-0.912
IBEX	-0.91
CLRO	-0.907
IMMR	-0.905
STIM	-0.899
SEDG	-0.896

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Champions Oncology Inc Financials

Annual	2023
Revenue:	$53.87M
Gross Profit:	$24.34M (45.18 %)
EPS:	$-0.390

Q3	2024
Revenue:	$12.02M
Gross Profit:	$4.17M (34.70 %)
EPS:	$-0.190

Q2	2024
Revenue:	$11.57M
Gross Profit:	$4.96M (42.82 %)
EPS:	$-0.150

Q1	2024
Revenue:	$12.56M
Gross Profit:	$4.88M (38.83 %)
EPS:	$-0.190

Financial Reports:

No articles found.

Champions Oncology Inc

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. The company provides Lumin Bioinformatics, a software platform and data tool that contains comprehensive information derived from research services and clinical studies, and sold on an annual subscriptions basis. The company markets its products through internet, word of mouth, and sales force to patients and physicians. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.